30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Cara Therapeutics Inc (CARA)

Track

The most recent insider trading activity occurred on February 28, 2025, with President and CEO Christopher Posner and Secretary Scott Terrillion executing planned sales. These transactions involved a total of 746 shares valued at approximately $3,545.13. Prior to this, on February 4, 2025, Mr. Posner also made a planned sale.
Stock chart
Ticker: CARA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Terrillion Scott
SEC'Y; CHIEF COMPLIANCE & G.C.
1 sale — total 776 USD
Planned sale 28 Feb 2025
Value US$238,005.81 | Price 197.70 | Shares 59,770
Planned sale 28 Feb 2025
Value US$4,598,565.56 | Price 260.90 | Shares 58,638
Planned sale 4 Feb 2025
Value US$1,755.84 | Price 4.72 | Shares 372
Planned sale 4 Nov 2024
Value US$1,063.72 | Price 0.29 | Shares 3,668
Planned sale 1 Aug 2024
Value US$1,452.15 | Price 0.35 | Shares 4,149
Planned sale 2 May 2024
Value US$2,952.00 | Price 0.75 | Shares 3,936
Planned sale 5 Apr 2024
Value US$2,284.99 | Price 0.83 | Shares 2,753
Planned sale 5 Apr 2024
Value US$2,284.99 | Price 0.83 | Shares 2,753
Planned sale 29 Feb 2024
Value US$5,192.26 | Price 0.89 | Shares 5,834
Planned sale 29 Feb 2024
Value US$2,930.77 | Price 0.89 | Shares 3,293
Planned sale 29 Feb 2024
Value US$2,930.77 | Price 0.89 | Shares 3,293
Planned sale 8 Feb 2024
Value US$18,854.75 | Price 0.53 | Shares 35,575
Planned sale 1 Feb 2024
Value US$2,739.55 | Price 0.55 | Shares 4,981
Planned sale 2 Nov 2023
Value US$4,631.12 | Price 1.22 | Shares 3,796
Planned sale 3 Aug 2023
Value US$13,222.49 | Price 3.07 | Shares 4,307
Planned sale 23 Jun 2023
Value US$10,505.43 | Price 3.51 | Shares 2,993
Planned sale 23 Jun 2023
Value US$9,557.73 | Price 3.51 | Shares 2,723
Planned sale 23 Jun 2023
Value US$8,715.33 | Price 3.51 | Shares 2,483
Planned sale 5 May 2023
Value US$17,023.60 | Price 4.40 | Shares 3,869
Planned sale 4 Apr 2023
Value US$12,181.71 | Price 4.91 | Shares 2,481
Planned sale 4 Apr 2023
Value US$13,419.03 | Price 4.91 | Shares 2,733
Planned sale 4 Apr 2023
Value US$12,181.71 | Price 4.91 | Shares 2,481
Planned sale 3 Mar 2023
Value US$60,745.76 | Price 9.71 | Shares 6,256
Planned sale 3 Mar 2023
Value US$58,133.77 | Price 9.71 | Shares 5,987
Planned sale 3 Mar 2023
Value US$66,047.42 | Price 9.71 | Shares 6,802
Planned sale 3 Mar 2023
Value US$60,405.91 | Price 9.71 | Shares 6,221
Planned sale 16 Feb 2023
Value US$23,103.00 | Price 10.20 | Shares 2,265
Planned sale 8 Feb 2023
Value US$2,908.64 | Price 0.53 | Shares 5,488
Planned sale 8 Feb 2023
Value US$4,118.10 | Price 0.53 | Shares 7,770
Planned sale 8 Feb 2023
Value US$4,118.10 | Price 0.53 | Shares 7,770
Planned sale 2 Feb 2023
Value US$49,453.80 | Price 11.80 | Shares 4,191
Planned sale 17 Jan 2023
Value US$24,484.65 | Price 10.81 | Shares 2,265
Planned sale 29 Dec 2022
Value US$23,057.70 | Price 10.18 | Shares 2,265
Planned sale 21 Dec 2022
Value US$39,512.62 | Price 11.27 | Shares 3,506
Planned sale 21 Dec 2022
Value US$28,862.47 | Price 11.27 | Shares 2,561
Planned sale 21 Dec 2022
Value US$33,719.84 | Price 11.27 | Shares 2,992
Planned sale 16 Nov 2022
Value US$161,051.10 | Price 11.13 | Shares 14,470
Sale 14 Sep 2022
Value US$111,024.00 | Price 10.28 | Shares 10,800
Planned sale 15 Jul 2022
Value US$65,160.00 | Price 9.05 | Shares 7,200
Planned sale 15 Jul 2022
Value US$32,580.00 | Price 9.05 | Shares 3,600
Planned sale 4 Apr 2022
Value US$25,416.02 | Price 12.67 | Shares 2,006
Planned sale 1 Apr 2022
Value US$21,247.44 | Price 11.91 | Shares 1,784
Planned sale 1 Apr 2022
Value US$19,556.22 | Price 11.91 | Shares 1,642
Planned sale 1 Apr 2022
Value US$19,556.22 | Price 11.91 | Shares 1,642
Planned sale 3 Mar 2022
Value US$20,336.06 | Price 11.38 | Shares 1,787
Planned sale 3 Mar 2022
Value US$23,260.72 | Price 11.38 | Shares 2,044
Planned sale 25 Feb 2022
Value US$20,291.88 | Price 10.29 | Shares 1,972
Planned sale 25 Feb 2022
Value US$21,753.06 | Price 10.29 | Shares 2,114
Planned sale 25 Feb 2022
Value US$20,291.88 | Price 10.29 | Shares 1,972
Sale 12 Nov 2021
Value US$131,207.20 | Price 16.04 | Shares 8,180
Planned sale 1 Nov 2021
Value US$17,150.00 | Price 17.15 | Shares 1,000
Planned sale 27 Oct 2021
Value US$15,000.00 | Price 15.00 | Shares 1,000
Planned sale 30 Aug 2021
Value US$24,977.80 | Price 14.20 | Shares 1,759
Planned sale 7 Jun 2021
Value US$30,044.16 | Price 13.04 | Shares 2,304
Planned sale 7 Jun 2021
Value US$112,752.00 | Price 13.05 | Shares 8,640
Planned sale 7 Jun 2021
Value US$32,886.00 | Price 13.05 | Shares 2,520
Planned sale 22 Mar 2021
Value US$58,950.00 | Price 19.65 | Shares 3,000
Planned sale 5 Mar 2021
Value US$55,791.94 | Price 17.98 | Shares 3,103
Planned sale 5 Mar 2021
Value US$55,612.14 | Price 17.98 | Shares 3,093
Planned sale 5 Mar 2021
Value US$60,376.84 | Price 17.98 | Shares 3,358
Planned sale 5 Mar 2021
Value US$55,558.20 | Price 17.98 | Shares 3,090
Planned sale 25 Feb 2021
Value US$96,707.99 | Price 19.33 | Shares 5,003
Planned sale 25 Feb 2021
Value US$77,397.32 | Price 19.33 | Shares 4,004
Planned sale 25 Feb 2021
Value US$226,721.57 | Price 19.33 | Shares 11,729
Planned sale 25 Feb 2021
Value US$65,180.76 | Price 19.33 | Shares 3,372
Planned sale 22 Feb 2021
Value US$39,460.00 | Price 19.73 | Shares 2,000
Planned sale 21 Jan 2021
Value US$40,240.00 | Price 20.12 | Shares 2,000
Planned sale 30 Dec 2020
Value US$29,773.80 | Price 15.30 | Shares 1,946
Planned sale 30 Dec 2020
Value US$92,993.40 | Price 15.30 | Shares 6,078
Planned sale 30 Dec 2020
Value US$43,023.60 | Price 15.30 | Shares 2,812
Planned sale 30 Dec 2020
Value US$19,859.40 | Price 15.30 | Shares 1,298
Planned sale 28 Dec 2020
Value US$80,000.00 | Price 16.00 | Shares 5,000
Planned sale 21 Dec 2020
Value US$30,000.00 | Price 15.00 | Shares 2,000
Sale 16 Dec 2020
Value US$74,750.00 | Price 14.95 | Shares 5,000
Sale 10 Dec 2020
Value US$114,675.00 | Price 15.29 | Shares 7,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-04 2025-02-28 PlS Planned sale
Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C.

Officer
59,770 +31.7%
197.70
US$238,006 		59,770 +31.7% 197.70 US$238,006
2025-03-04 2025-02-28 PlS Planned sale
1.4
Posner Christopher

PRESIDENT AND CEO

Executive Director
58,638 -10.8%
260.90
US$4,598,566 		58,638 -10.8% 260.90 US$4,598,566
2025-02-06 2025-02-04 PlS Planned sale
1.4
Posner Christopher

PRESIDENT AND CEO

Executive Director
16,664 +4.0%
115.74
US$4,735,688 		16,664 +4.0% 115.74 US$4,735,688
2024-11-06 2024-11-04 PlS Planned sale
1.4
Posner Christopher

PRESIDENT AND CEO

Executive Director
3,668 -2.1%
0.29
US$1,064 		3,668 -2.1% 0.29 US$1,064
2024-08-02 2024-08-01 PlS Planned sale
1.4
Posner Christopher

PRESIDENT AND CEO

Executive Director
4,149 -2.3%
0.35
US$1,452 		4,149 -2.3% 0.35 US$1,452
2024-05-06 2024-05-02 PlS Planned sale
1.4
Posner Christopher

PRESIDENT AND CEO

Executive Director
3,936 -2.2%
0.75
US$2,952 		3,936 -2.2% 0.75 US$2,952
2024-04-09 2024-04-05 PlS Planned sale
Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C.

Officer
2,753 -3.0%
0.83
US$2,285 		2,753 -3.0% 0.83 US$2,285
2024-04-09 2024-04-05 PlS Planned sale
Goncalves Joana

CHIEF MEDICAL OFFICER

Officer
2,753 -4.9%
0.83
US$2,285 		2,753 -4.9% 0.83 US$2,285
2024-03-04 2024-02-29 PlS Planned sale
1.4
Posner Christopher

PRESIDENT AND CEO

Executive Director
5,834 -3.1%
0.89
US$5,192 		5,834 -3.1% 0.89 US$5,192
2024-03-04 2024-02-29 PlS Planned sale
Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C.

Officer
3,293 -3.5%
0.89
US$2,931 		3,293 -3.5% 0.89 US$2,931
2024-03-04 2024-02-29 PlS Planned sale
Goncalves Joana

CHIEF MEDICAL OFFICER

Officer
3,293 -5.5%
0.89
US$2,931 		3,293 -5.5% 0.89 US$2,931
2024-02-12 2024-02-08 PlS Planned sale
1.4
Posner Christopher

PRESIDENT AND CEO

Executive Director
35,575 -16.0%
0.53
US$18,855 		35,575 -16.0% 0.53 US$18,855
2024-02-05 2024-02-01 PlS Planned sale
1.4
Posner Christopher

PRESIDENT AND CEO

Executive Director
4,981 -2.2%
0.55
US$2,740 		4,981 -2.2% 0.55 US$2,740
2023-11-03 2023-11-02 PlS Planned sale
1.4
Posner Christopher

President and CEO

Executive Director
3,796 -2.3%
1.22
US$4,631 		3,796 -2.3% 1.22 US$4,631
2023-08-04 2023-08-03 PlS Planned sale
1.4
Posner Christopher

President and CEO

Executive Director
4,307 -2.5%
3.07
US$13,222 		4,307 -2.5% 3.07 US$13,222
2023-06-27 2023-06-23 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
2,993 -1.9%
3.51
US$10,505 		2,993 -1.9% 3.51 US$10,505
2023-06-27 2023-06-23 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,723 -4.8%
3.51
US$9,558 		2,723 -4.8% 3.51 US$9,558
2023-06-27 2023-06-23 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
2,483 -2.7%
3.51
US$8,715 		2,483 -2.7% 3.51 US$8,715
2023-05-09 2023-05-05 PlS Planned sale
1.4
Posner Christopher

President and CEO

Executive Director
3,869 -2.2%
4.40
US$17,024 		3,869 -2.2% 4.40 US$17,024
2023-04-06 2023-04-04 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
2,481 -2.7%
4.91
US$12,182 		2,481 -2.7% 4.91 US$12,182
2023-04-06 2023-04-04 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
2,733 -1.7%
4.91
US$13,419 		2,733 -1.7% 4.91 US$13,419
2023-04-06 2023-04-04 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,481 -4.2%
4.91
US$12,182 		2,481 -4.2% 4.91 US$12,182
2023-03-07 2023-03-03 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
6,256 -6.3%
9.71
US$60,746 		6,256 -6.3% 9.71 US$60,746
2023-03-07 2023-03-03 PlS Planned sale
1.4
Posner Christopher

President and CEO

Executive Director
5,987 -3.3%
9.71
US$58,134 		5,987 -3.3% 9.71 US$58,134
2023-03-07 2023-03-03 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
6,802 -4.1%
9.71
US$66,047 		6,802 -4.1% 9.71 US$66,047
2023-03-07 2023-03-03 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
6,221 -9.6%
9.71
US$60,406 		6,221 -9.6% 9.71 US$60,406
2023-02-17 2023-02-16 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,265 -3.4%
10.20
US$23,103 		2,265 -3.4% 10.20 US$23,103
2024-02-12 2023-02-08 PlS Planned sale
3.3
Maynard Ryan D

CHIEF FINANCIAL OFFICER

Officer
5,488 -40.7%
0.53
US$2,909 		5,488 -40.7% 0.53 US$2,909
2024-02-12 2023-02-08 PlS Planned sale
Goncalves Joana

CHIEF MEDICAL OFFICER

Officer
7,770 -11.6%
0.53
US$4,118 		7,770 -11.6% 0.53 US$4,118
2024-02-12 2023-02-08 PlS Planned sale
Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C.

Officer
7,770 -7.6%
0.53
US$4,118 		7,770 -7.6% 0.53 US$4,118
2023-02-03 2023-02-02 PlS Planned sale
1.4
Posner Christopher

President and CEO

Executive Director
4,191 -2.2%
11.80
US$49,454 		4,191 -2.2% 11.80 US$49,454
2023-01-19 2023-01-17 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,265 -3.3%
10.81
US$24,485 		2,265 -3.3% 10.81 US$24,485
2023-01-03 2022-12-29 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,265 -3.2%
10.18
US$23,058 		2,265 -3.2% 10.18 US$23,058
2022-12-23 2022-12-21 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
3,506 -2.1%
11.27
US$39,513 		3,506 -2.1% 11.27 US$39,513
2022-12-23 2022-12-21 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
2,561 -2.5%
11.27
US$28,862 		2,561 -2.5% 11.27 US$28,862
2022-12-23 2022-12-21 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,992 -4.0%
11.27
US$33,720 		2,992 -4.0% 11.27 US$33,720
2022-11-18 2022-11-16 PlS Planned sale
1.4
Posner Christopher

President and CEO

Executive Director
14,470 -7.2%
11.13
US$161,051 		14,470 -7.2% 11.13 US$161,051
2022-09-16 2022-09-14 S Sale
2.0
VOGELBAUM MARTIN
Non-Executive Director
10,800 -19.4%
10.28
US$111,024 		10,800 -19.4% 10.28 US$111,024
2022-07-19 2022-07-15 PlS Planned sale
BAINS HARRISON M JR
Non-Executive Director
7,200 -22.3%
9.05
US$65,160 		7,200 -22.3% 9.05 US$65,160
2022-07-19 2022-07-15 PlS Planned sale
3.3
Ives Jeffrey L.
Non-Executive Director
3,600 -18.9%
9.05
US$32,580 		3,600 -18.9% 9.05 US$32,580
2022-04-05 2022-04-04 PlS Planned sale
1.4
Posner Christopher

President and CEO

Executive Director
2,006 -1.0%
12.67
US$25,416 		2,006 -1.0% 12.67 US$25,416
2022-04-05 2022-04-01 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
1,784 -1.0%
11.91
US$21,247 		1,784 -1.0% 11.91 US$21,247
2022-04-05 2022-04-01 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,642 -1.6%
11.91
US$19,556 		1,642 -1.6% 11.91 US$19,556
2022-04-05 2022-04-01 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
1,642 -2.1%
11.91
US$19,556 		1,642 -2.1% 11.91 US$19,556
2022-03-04 2022-03-03 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,787 -1.7%
11.38
US$20,336 		1,787 -1.7% 11.38 US$20,336
2022-03-04 2022-03-03 PlS Planned sale
Reilly Thomas Charles

Chief Financial Officer

Officer
2,044 -5.1%
11.38
US$23,261 		2,044 -5.1% 11.38 US$23,261
2022-03-01 2022-02-25 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,972 -1.9%
10.29
US$20,292 		1,972 -1.9% 10.29 US$20,292
2022-03-01 2022-02-25 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
2,114 -1.2%
10.29
US$21,753 		2,114 -1.2% 10.29 US$21,753
2022-03-01 2022-02-25 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
1,972 -2.5%
10.29
US$20,292 		1,972 -2.5% 10.29 US$20,292
2021-11-16 2021-11-12 S Sale
3.3
Ives Jeffrey L.
Non-Executive Director
8,180 -53.2%
16.04
US$131,207 		8,180 -53.2% 16.04 US$131,207
2021-11-03 2021-11-01 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
1,000 -2.1%
17.15
US$17,150 		1,000 -2.1% 17.15 US$17,150
2021-10-28 2021-10-27 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
1,000 -2.1%
15.00
US$15,000 		1,000 -2.1% 15.00 US$15,000
2021-09-01 2021-08-30 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,759 -2.4%
14.20
US$24,978 		1,759 -2.4% 14.20 US$24,978
2021-06-07 2021-06-07 PlS Planned sale
1.4
Posner Christopher
Non-Executive Director
2,304 -12.5%
13.04
US$30,044 		2,304 -12.5% 13.04 US$30,044
2021-06-07 2021-06-07 PlS Planned sale
2.0
VOGELBAUM MARTIN
Non-Executive Director
8,640 -30.0%
13.05
US$112,752 		8,640 -30.0% 13.05 US$112,752
2021-06-07 2021-06-07 PlS Planned sale
3.3
Ives Jeffrey L.
Non-Executive Director
2,520 -14.1%
13.05
US$32,886 		2,520 -14.1% 13.05 US$32,886
2021-03-24 2021-03-22 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
3,000 -8.9%
19.65
US$58,950 		3,000 -8.9% 19.65 US$58,950
2021-03-08 2021-03-05 PlS Planned sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
3,103 -0.3%
17.98
US$55,792 		3,103 -0.3% 17.98 US$55,792
2021-03-08 2021-03-05 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
3,093 -8.4%
17.98
US$55,612 		3,093 -8.4% 17.98 US$55,612
2021-03-08 2021-03-05 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
3,358 -2.7%
17.98
US$60,377 		3,358 -2.7% 17.98 US$60,377
2021-03-08 2021-03-05 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
3,090 -5.7%
17.98
US$55,558 		3,090 -5.7% 17.98 US$55,558
2021-02-25 2021-02-25 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
5,003 -4.3%
19.33
US$96,708 		5,003 -4.3% 19.33 US$96,708
2021-02-25 2021-02-25 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
4,004 -8.3%
19.33
US$77,397 		4,004 -8.3% 19.33 US$77,397
2021-02-25 2021-02-25 PlS Planned sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
11,729 -1.2%
19.33
US$226,722 		11,729 -1.2% 19.33 US$226,722
2021-02-25 2021-02-25 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
3,372 -11.2%
19.33
US$65,181 		3,372 -11.2% 19.33 US$65,181
2021-02-24 2021-02-22 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,000 -7.1%
19.73
US$39,460 		2,000 -7.1% 19.73 US$39,460
2021-01-25 2021-01-21 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,000 -6.7%
20.12
US$40,240 		2,000 -6.7% 20.12 US$40,240
2020-12-30 2020-12-30 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,946 -4.4%
15.30
US$29,774 		1,946 -4.4% 15.30 US$29,774
2020-12-30 2020-12-30 PlS Planned sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
6,078 -0.6%
15.30
US$92,993 		6,078 -0.6% 15.30 US$92,993
2020-12-30 2020-12-30 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
2,812 -2.5%
15.30
US$43,024 		2,812 -2.5% 15.30 US$43,024
2020-12-30 2020-12-30 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
1,298 -4.1%
15.30
US$19,859 		1,298 -4.1% 15.30 US$19,859
2020-12-29 2020-12-28 PlS Planned sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
5,000 -0.5%
16.00
US$80,000 		5,000 -0.5% 16.00 US$80,000
2020-12-23 2020-12-21 PlS Planned sale
Goncalves Joana

Chief Medical Officer

Officer
2,000 -6.8%
15.00
US$30,000 		2,000 -6.8% 15.00 US$30,000
2020-12-18 2020-12-16 S Sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
5,000 -0.5%
14.95
US$74,750 		5,000 -0.5% 14.95 US$74,750
2020-12-11 2020-12-10 S Sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
7,500 -0.8%
15.29
US$114,675 		7,500 -0.8% 15.29 US$114,675
Explore more

More insider trading research around Cara Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America